1. Home
  2. SCPH vs NKSH Comparison

SCPH vs NKSH Comparison

Compare SCPH & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • NKSH
  • Stock Information
  • Founded
  • SCPH 2013
  • NKSH 1891
  • Country
  • SCPH United States
  • NKSH United States
  • Employees
  • SCPH N/A
  • NKSH N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • NKSH Major Banks
  • Sector
  • SCPH Health Care
  • NKSH Finance
  • Exchange
  • SCPH Nasdaq
  • NKSH Nasdaq
  • Market Cap
  • SCPH 173.6M
  • NKSH 162.0M
  • IPO Year
  • SCPH 2017
  • NKSH N/A
  • Fundamental
  • Price
  • SCPH $2.44
  • NKSH $26.14
  • Analyst Decision
  • SCPH Strong Buy
  • NKSH Strong Buy
  • Analyst Count
  • SCPH 3
  • NKSH 1
  • Target Price
  • SCPH $14.00
  • NKSH $38.00
  • AVG Volume (30 Days)
  • SCPH 237.4K
  • NKSH 11.1K
  • Earning Date
  • SCPH 05-16-2025
  • NKSH 05-19-2025
  • Dividend Yield
  • SCPH N/A
  • NKSH 5.84%
  • EPS Growth
  • SCPH N/A
  • NKSH N/A
  • EPS
  • SCPH N/A
  • NKSH 1.38
  • Revenue
  • SCPH $36,332,000.00
  • NKSH $46,211,000.00
  • Revenue This Year
  • SCPH $109.32
  • NKSH $1.17
  • Revenue Next Year
  • SCPH $76.95
  • NKSH $9.78
  • P/E Ratio
  • SCPH N/A
  • NKSH $18.89
  • Revenue Growth
  • SCPH 167.28
  • NKSH 2.21
  • 52 Week Low
  • SCPH $1.94
  • NKSH $23.75
  • 52 Week High
  • SCPH $5.65
  • NKSH $33.37
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 46.18
  • NKSH 52.22
  • Support Level
  • SCPH $2.24
  • NKSH $25.16
  • Resistance Level
  • SCPH $2.64
  • NKSH $26.83
  • Average True Range (ATR)
  • SCPH 0.17
  • NKSH 0.81
  • MACD
  • SCPH 0.01
  • NKSH 0.14
  • Stochastic Oscillator
  • SCPH 38.46
  • NKSH 60.32

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About NKSH National Bankshares Inc.

National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.

Share on Social Networks: